1.

Record Nr.

UNINA9910817000303321

Autore

Mirzayans Razmik

Titolo

Cellular senescence [[electronic resource] ] : implications for cancer therapy / / Razmik Mirzayans and David Murray

Pubbl/distr/stampa

New York, : Nova Biomedical Books, c2009

ISBN

1-61728-173-5

Edizione

[1st ed.]

Descrizione fisica

113 p. : ill. (some col.)

Altri autori (Persone)

MurrayDavid, Ph. D.

Soggetti

Cells - Aging

Cancer - Treatment

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Bibliographic Level Mode of Issuance: Monograph

Nota di bibliografia

Includes bibliographical references (p. [75]-100) and index.

Nota di contenuto

Intro -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CELLULAR SENESCENCE: IMPLICATIONS FOR CANCER THERAPY -- CONTENTS -- PREFACE -- Chapter 1   INTRODUCTION -- Chapter 2   TELOMERASE-BASED SENESCENCE -- Chapter 3   STRESS-TRIGGERED PREMATURE  SENESCENCE -- Chapter 4   FEATURES OF PREMATURE SENESCENCE -- CELL MORPHOLOGY -- SENESCENCE-ASSOCIATED β-GALACTOSIDASE EXPRESSION -- SUSTAINED P21 UP-REGULATION -- INHIBITION OF CELL GROWTH -- NUCLEAR ACCUMULATION OF ACTIN -- STRESS-ASSOCIATED NUCLEAR FOCI -- Chapter 5   DIFFERENT MODES OF GROWTH  ARREST ARE TRIGGERED BY GENOTOXIC STRESS -- Chapter 6   CLASSIFICATION OF CDK INHIBITORS -- Chapter 7   ROLES OF P21, P53 AND P16  IN SENESCENCE -- Chapter 8   REGULATION OF P21WAF1 TRANSCRIPT  AND P21 PROTEIN LEVELS -- Chapter 9   MODE OF ACTION OF P21 -- Chapter 10   P53 SIGNALING AND CELLULAR  RESPONSE TO DNA-DAMAGING AGENTS -- IONIZING RADIATION-TRIGGERED RESPONSES -- UV-TRIGGERED RESPONSES -- APOPTOTIC THRESHOLD IN CANCER CELLS EXPOSED TO DNA-DAMAGING AGENTS -- WHAT FACTORS MIGHT CONTRIBUTE TO THE APOPTOTIC THRESHOLD? -- Chapter 11   CELL-TO-CELL COMMUNICATION  TRIGGERED BY DNA-DAMAGING AGENTS -- ROS-ASSOCIATED BYSTANDER EFFECT OF RADIATION -- P53-MEDIATED BYSTANDER EFFECT OF RADIATION -- DIFFUSIBLE "AT-CORRECTING" FACTORS -- Chapter 12   MODULATING SENESCENCE IN THE  CONTEXT OF CANCER



THERAPY -- PROS AND CONS OF ACTIVATING SENESCENCE IN CANCER CELLS -- ASSAYS FOR PRECLINICAL TESTING OF ANTICANCER AGENTS -- Chapter 13   AGING, SENESCENCE, AND "HORMESIS" -- Chapter 14   HUMAN GENETIC DISORDERS  ASSOCIATED WITH GENOMIC INSTABILITY AND CANCER PREDISPOSITION -- WERNER SYNDROME -- HUTCHINSON-GILFORD'S PROGERIA SYNDROME -- BLOOM SYNDROME -- ROTHMUND-THOMPSON SYNDROME -- COCKAYNE SYNDROME -- XERODERMA PIGMENTOSUM -- FANCONI ANEMIA -- ATAXIA TELANGIECTASIA -- LI-FRAUMENI SYNDROME.

Chapter 15   BIOLOGICAL CONSEQUENCES OF THE  FAILURE OF CELLS TO UNDERGO SENESCENCE/APOPTOSIS FOLLOWING GENOTOXIC STRESS: BASIS FOR THE EMERGENCE OF HIGHLY METASTATIC AND THERAPY-RESISTANT DISEASE? -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX -- Blank Page.